Aaron L. Sabbota

Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.

Shijie Sheng, S. Sheng, M. Cher, 2008, Neoplasia.

Young-IFSO Bariatric/Metabolic Surgery Training and Education Survey

Gabriel A. Carrizo, Derek K. Rogalsky, G. Martines, 2023, Obesity Surgery.

Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism‐based selective gelatinase inhibitor

M. Bernardo, R. Fridman, S. Mobashery, 2006, International journal of cancer.

CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone

M. Cher, R. Bonfil, Z. Dong, 2008, Molecular Cancer Research.

Heterogeneous Activation of MMP-9 Due to Prostate Cancer-Bone Interaction

M. Cher, R. Bonfil, Z. Dong, 2007 .

Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.

R. Fridman, H. Kim, M. Cher, 2010, Cancer research.

Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP‐12 dependent manner

M. Cher, R. Bonfil, Z. Dong, 2008, International journal of cancer.

Prostate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.

R. Vessella, R. Fridman, J. T. Trindade Filho, 2007, The American journal of pathology.

Predictors of 30-day follow-up visit completion after primary bariatric surgery: an analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program data registry.

Aaron L Sabbota, S. Groth, Yang Yu, 2021, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study.

P. Gentileschi, G. Marinari, G. Martines, 2024, Obesity surgery.